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Fueled by widespread applications of high-throughput next generation sequencing (NGS) technologies and urgent
need to counter threats of pathogenic viruses, large-scale studies were conducted recently to investigate virus
integration in host genomes (for example, human tumor genomes) that may cause carcinogenesis or other
diseases. A limiting factor in these studies, however, is rapid virus evolution and resulting polymorphisms, which
prevent reads from aligning readily to commonly used virus reference genomes, and, accordingly, make virus
integration sites difficult to detect. Another confounding factor is host genomic instability as a result of virus
insertions. To tackle these challenges and improve our capability to identify cryptic virus-host fusions, we present
a new approach that detects Virus intEgration sites through iterative Reference SEquence customization (VERSE).
To the best of our knowledge, VERSE is the first approach to improve detection through customizing reference
genomes. Using 19 human tumors and cancer cell lines as test data, we demonstrated that VERSE substantially
enhanced the sensitivity of virus integration site detection. VERSE is implemented in the open source package
VirusFinder 2 that is available at http://bioinfo.mc.vanderbilt.edu/VirusFinder/.Background
Pathogenic viruses pose significant threats to public
health throughout the world [1,2]. With rapid advances
in next generation sequencing (NGS) technologies over
the past several years and their potential to unbiasedly
and comprehensively identify pathogens in clinical sam-
ples [3-6], numerous studies were conducted recently to
shed light on disease-associated viruses, such as hepatitis
B virus (HBV), human immunodeficiency virus (HIV),
and human papillomavirus (HPV). One notable develop-
ment, which has greatly enhanced our knowledge of the
molecular mechanisms of viruses in tumor development,
is the use of NGS to survey virus integration in cancer
genomes among large cohorts of cancer patients [7-9] as
well as their effects on host cell gene expression [10,11].
Virus insertions in host genomes typically cause host
genomic instability [7-9], which is often evidenced by* Correspondence: zhongming.zhao@vanderbilt.edu
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tations (and the homology between the viral and host
genomes) make the alignment of short reads to the host
reference genomes difficult and, consequently, the detec-
tion of virus integration sites challenging. Another factor
that adversely impacts the detection is viral sequence di-
vergence as a result of high virus mutation rates [12,13],
which makes the NGS reads sampled from the real virus
genomes less likely to align to the commonly used virus
reference sequences. The rapid genetic changes of the
virus sequences require customized (or personalized) virus
references that can take into account virus polymorphisms
and evolution.
Stimulated by the strong demand for NGS investiga-
tions of virus-host interactions, a large number of tools
were developed in the past three years for virus/virome
characterization [14-20], novel infectious agent detection
[14,21], and virus mutation spectrum analysis [22-25].
Along with progress in computational technologies and
improvements in the NGS technologies, software
designed specifically to detect virus integration in host
genomes has also emerged, for example, VirusSeq [26],This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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However, these tools align NGS reads directly to the
known virus and host reference genomes and, hence,
cannot tackle effectively the challenges posed by virus-
induced host genomic instability and viral genome vari-
ability. To improve our capability to identify cryptic
virus-host fusions, novel approaches are still urgently
required.
To facilitate the rapidly growing number of studies on
disease-associated viruses, here we present a new ap-
proach that detects Virus intEgration sites through Ref-
erence SEquence customization (VERSE). The rationale
of VERSE is to use short reads to iteratively 'correct' ref-
erence genomes so as to create new 'personalized' refer-
ence genomes. Corrections made to the references
improve read mapability, and, accordingly, detection
sensitivity. VERSE is specifically designed with the diver-
sity and scale of today’s NGS applications and computa-
tional efficiency in mind. It allows quick analysis of NGS
data of various types: whole genome sequencing (WGS),
whole transcriptome sequencing (RNA-seq), targeted se-
quencing (TS), and so on. VERSE is implemented in a
publicly available software package, VirusFinder [30]. In
its sensitive detection mode (see the user’s manual at
[30]), VirusFinder runs VERSE to characterize virus inte-
gration loci.
Methods
Next generation sequencing data
We used WGS of 13 hepatocellular carcinomas (HCCs),
RNA-seq of 4 HCC cell lines, and TS of 2 Merkel cell
carcinomas to evaluate VERSE (Table 1). All these sam-
ples are publicly available and were validated to harbor
virus integration sites.
Paired-end WGS (2 × 90 bp) of the 13 HCCs was per-
formed on an Illumina HiSeq 2000 sequencer as de-
scribed in [7]. Average coverage of these samples ranged
from 31.7× to 121.2× (Table S1 in Additional file 1). The
HBV integration sites identified in these samples were
validated using PCR and Sanger resequencing [7]. In
total, 22 integration events were validated in these
tumor samples. Several samples harbored virus integra-
tion sites that were very close to each other. For ex-
ample, the two HBV insertion sites in sample 145 T,
chr19: 30303492 and chr19: 30303498, were only 6 bpTable 1 Human tumor samples that harbor validated virus in
Tumor type Virus Number of samples Sequencing techn
Hepatocellular carcinoma HBV 13 WGS
Hepatocellular carcinoma HBV 4 RNA-seq
Merkel cell carcinoma MCV 2 TS
aTwo virus insertion loci were considered as one if the genomic distance between t
polyomavirus; NA, no accession number is associated with the project; RNA-seq, wh
genome sequencing.away (Table S1 in Additional file 1). The discrimination
of virus integration sites within this short distance is
quite beyond the capability of current detection tools.
Because VERSE applies a 10 bp cutoff to filter out low-
confidence detections, we regarded two virus insertion
loci as one if the distance between them was less than
10 bp. This gave us a final set of 20 virus integration
sites for these samples.
Whole transcriptomes of the four HCC cell lines were
subjected to sequencing library preparation using an
Illumina TruSeq RNA Sample Preparation Kit as re-
ported in the original publication [11]. Sequencing was
performed on an Illumina HiSeq 2000 platform, generat-
ing paired-end reads of length 101 bp with an average
insertion size of 300 bp (Table S2 in Additional file 1).
On average, 127 million reads were obtained per sample.
Eleven chimeric HBV-human transcripts were detected
in these samples using ViralFusionSeq [27] and validated
using Sanger resequencing.
For the two Merkel cell carcinomas, virus genomes
were captured from formalin-fixed, paraffin-embedded
tissues and enriched using PCR-generated capture
probes [31]. Targeted paired-end sequencing was per-
formed on an Illumina GAIIx platform (2 × 100 bp). In
total, 3.9 and 5.0 million reads were produced for the
two samples, respectively. The viral integration sites in
the tumor genomes were detected using both BreakDancer
[32] and SLOPE [33]. To validate the identified virus inser-
tion events, primers were designed using Vector NTI suite
(Invitrogen). For a detailed validation protocol, interested
readers are referred to [31].
Besides the data from the real tumors and cancer cell
lines, we also simulated WGS of human chromosome 1
using the profile-based Illumina pair-end Read Simulator
(pIRS) [34]. We plugged a mutated copy of the HPV-16
virus reference genome (GI:310698439) into chromo-
some 1 of UCSC hg19 to create a new reference with
which to run the command 'simulate' in pIRS to gener-
ate paired-end sequencing reads (insert size: 200 bp;
read length: 2 × 75 bp; average coverage: 30×). Addition-
ally, to mimic real data, we inserted single nucleotide
polymorphisms (SNPs), small insertions and deletions
(indels), and structural variants (SVs) into the data. We
let the frequency of SNPs be 10 times higher than that
of indels and the frequency of SVs 10 times less thantegration sites




hem was less than 10 bp. HBV, hepatitis B virus; MCV, Merkel cell
ole transcriptome sequencing; TS, targeted sequencing; WGS, whole
Wang et al. Genome Medicine  (2015) 7:2 Page 3 of 8that of indels. The simulation data are freely available at
[30].
VERSE pipeline
Figure 1 illustrates the VERSE pipeline, which overall follows
a four-step procedure: (a) read subtraction, (b) virus genome
customization, (c) host genome customization, and (d) virus
integration site detection.
Read subtraction
The purpose of the read subtraction step is to collect
viral reads, that is, the reads characteristic of the viruses
infecting a host. In this step, VERSE uses the alignment
tool Bowtie 2 [35] to map raw sequencing reads to the
reference genome of the host species under study.Figure 1 Workflow of VERSE. (a) Reads are aligned to a host reference g
called viral reads. To differentiate mapped reads in the figure from unmapp
mapped reads is changed from grey to the color of the host genomic regi
reference genome. The high-quality consensus SNPs and indels detected
(c) The consensus virus genome created is concatenated to the host refe
chrVirus). Next, the viral reads are mapped to the resulting new reference
aligned reads. The SVs involving both the host genome and chrVirus are
Finally, using the same procedure as in (b), the identified host genomic regio
concatenated with the consensus virus genome. The viral reads are mapped
breakpoints of the SVs that involve both the virus and host genomes, if there
lines represent virus integration breakpoints.Bowtie 2 is run in its sensitive end-to-end mode in order
to achieve high alignment speed. Read pairs with one or
both ends unmapped to the host genome are garnered.
These reads are called viral reads for simplicity, although
not all of them are related to the viruses. VERSE ex-
ploits primarily the viral reads in order to detect virus
integrations.
Virus genome customization
In this step, VERSE utilizes ICORN [36], a tool for cor-
recting errors in small genomes, to customize virus ref-
erence genomes. Specifically, VERSE runs ICORN to
map viral reads to the virus reference genomes and to
identify SNPs and indels from the mapped reads. Only
high-quality consensus SNPs and indels are used toenome. Unmapped reads and read pairs with one end unmapped are
ed ones, which remain grey throughout the pipeline, the color of
on they are aligned to. (b) The viral reads are mapped to a virus
from aligned reads are used to modify the virus reference genome.
rence genome (designated as a separate pseudo-chromosome,
. Then, inter-chromosomal structural variants (SVs) are detected from
used to infer virus integration-harboring regions in the host genome.
ns are customized. (d) The modified host genomic regions are
to this new reference for the detection of inter-chromosomal SVs. The
are any, are reported as virus integration sites. In the figure, vertical dotted
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the coverage of the mapped reads at each base before
and after the modifications. The corrections that reduced
the coverage are rejected. The whole process, from read
alignment and variant detection to base correction, is run
iteratively. Typically, six iterations suffice to correct major-
ity errors in a small reference genome [36].
Host genome customization
Customization of large genomes is time-consuming. For
instance, to use short reads to modify the UCSC hg19, it
can take ICORN over a week to complete at the Vanderbilt
Advanced Computing Center for Research and Education
(ACCRE) [37]. To speed up VERSE, we extract genomic
regions from host genomes that are likely to harbor virus
integration sites. We run ICORN only on the identified
regions.
Specifically, we first combine the reference genome of
the host species under study with the consensus virus
genome created in the previous step (designated as a
separate pseudo-chromosome, chrVirus). Next, we use
BWA [38] to align the viral reads to the resulting new
reference. With the alignment file created, VERSE runs
SVDetect [39], a software tool that uses anomalously
mapped read pairs to localize genomic rearrangements,
to call inter-chromosomal SVs that involve both the host
genome and chrVirus. The host genomic regions that po-
tentially harbor virus integration sites are then derived from
the mapped positions of the reads of the SVs (Figure 1c(ii)).
These genomic regions are typically <10,000 bp in length,
significantly smaller than the host genome.
Next, VERSE designates each region characterized from
the host genome as a separate pseudo-chromosome. After
concatenating them together, VERSE recruits reads mapped
to these regions from the Bowtie 2-aligned file created
in step (a). Then, following the same procedure as step (b),
VERSE runs ICORN to iteratively align reads to these
pseudo-chromosomes, call SNPs and indels from read
alignment, and then correct the reference with the called
SNPs and indels.
The final outputs of this step are therefore customized
host genomic regions, each of which corresponds to a
potential virus integration event. By modifying only
these small regions, we are able to reduce the computa-
tion time from over a week on a large reference genome
to a few hours.
Virus integration detection
In this step, VERSE concatenates the host genomic re-
gions recruited in the previous step with the consensus
virus genome to create an analysis-ready reference gen-
ome. VERSE runs BWA to map the viral reads to this
new reference and then utilizes CREST [40] to detect
inter-chromosomal SVs. CREST is an algorithm thatexploits soft-clipped reads, the reads with partial align-
ments to the reference genomes, for SV identification.
The breakpoints of the SVs that involve both the virus
and host genomes, if there are any, are then reported as
virus integration sites.
Result classification and filtering
As demonstrated above, VERSE combines two comple-
mentary tools, SVDetect [39] and CREST [40], to
customize reference genomes and detect virus integra-
tion sites. SVDetect uses spanning reads, that is, paired-
end reads with one end mapped to the host genome and
another aligned to the virus genome, to characterize
virus integration loci. It is fast but not able to discern
integration breakpoints accurately. In contrast to
SVDetect, CREST utilizes soft-clipped reads, which are
potentially split reads that harbor virus integration
breakpoints within themselves. CREST is prone to miss
true-positive loci due to the difficulty to map split reads.
But it is able to determine virus integration sites
at single-base resolution. By combining SVDetect and
CREST, VERSE balances computational efficiency and
detection accuracy.
To measure the confidence of a predicted position
relative to the real virus integration site, and based on
the output of CREST, VERSE categorizes a prediction
into one of two classes: (a) high confidence - if there are
sufficient soft-clipped reads to support an integration
locus so that CREST is able to detect it; and (b) low con-
fidence - CREST fails to detect it for the lack of high-
quality soft-clipped reads.
For a high-confidence prediction, CREST’s output is
used directly as a putative virus integration site. For a
low-confidence one, however, VERSE predicts its pos-
ition based on the soft-clipped reads that cover it. In
particular, VERSE derives the boundaries of the region
that potentially harbor the integration site from the
output of SVDetect. Next, VERSE sorts the loci within
the boundaries in the descending order of the number
of soft-clipped reads that are aligned to them. The one
covered with the most soft-clipped reads is then used as
an estimate of the real integration locus.
To discard the possible false-positives, VERSE requires
the distance between two adjacent low-confidence virus
integration sites to be at least 10 bp. The drawback of
the use of this stringent cutoff is that VERSE could mis-
takenly discard a real integration event if it is within
10 bp of another.
Input of VERSE
The input of VERSE includes NGS reads (in FASTQ
format) sequenced from a host, a reference host gen-
ome (in FASTA format), and a reference virus genome
(FASTA format). The entire pipeline of VERSE, from
Table 2 Total number of SNPs and indels corrected for




Chr3:140,567,185-140,575,795 26 6 2
Chr6:33,823,990-33,832,089 0 0 0
Chr18:102,747-110,847 178 5 9
aThese three genomic regions were derived from SVDetect’s output. The last
region harbors a HBV integration site.
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detection to result classification and filtering, is fully
automated. The output of each step is used automatic-
ally as the input for the next step of the pipeline.
VERSE provides an argument sensitivity_level to allow
users to designate the number of iterations of reference
genome customization. Because the majority of errors in
a reference gnome can be corrected using one or two
rounds of ICORN iteration, when evaluating VERSE on
the human tumors and cell lines in the section below,
we let sensitivity_level = 1 for simplicity and to save time.
We encourage users to tune its value in their applica-
tions so as to adjust VERSE’s detection sensitivity.
Another input argument of VERSE is flank_region_size,
which defines the size of the flanking regions upstream
and downstream of a genomic region under study.
In our experiments presented in the section below,
flank_region_size was set to the default value of 4,000.
This means VERSE will search both the upstream
4,000 bp and downstream 4,000 bp regions flanking a
genomic segment predicted by SVDetect to harbor a
candidate virus integration site. By allowing VERSE to
examine the flanking regions, we reduce the chance to
miss virus insertion sites therein.
As mentioned above, the source code of VERSE is pub-
licly available, through the open source software package
VirusFinder 2 [30]. As the core module of VirusFinder 2,
VERSE is utilized by VirusFinder 2 to characterize virus
integration loci (in its sensitive detection mode; see user’s
manual at [30]).
Results and discussion
In this section, we first evaluate VERSE’s capability to
customize virus reference genomes. Then, we examine
the effect of host genome customization and VERSE’s
performance in identifying virus integration in human
tumor genomes. The utility of VERSE is available
through the VirusFinder 2 software.
Effect of virus genome customization
Although the viruses infecting the human tumors and
cancer cell lines collected by us were reported by earlier
studies, their consensus sequences are unknown to in-
vestigators. In order to estimate the resemblance of the
VERSE-created consensus virus genomes with the intra-
host virus populations, we ran VERSE on the simulation
data.
The mutated copy of the HPV-16 virus reference gen-
ome (GI:310698439) that was inserted in the simulation
data harbors 75 SNPs and 9 indels. VERSE recruited the
viral reads by aligning the raw simulated reads to the
UCSC hg19 sequence. Then, with the HPV-16 reference
genome as input, VERSE used the viral reads to
customize the HPV-16 reference. After one round ofICORN iteration, 68 (91%) out of 75 SNPs and 6 (67%)
out of 9 indels (relative to the assembly of short reads)
were successfully characterized in the HPV-16 reference
and corrected. This result demonstrates that VERSE
could accurately identify the consensus mutations of the
intra-host virus populations.
Next, we compared the consensus virus genome pro-
duced by VERSE with the initial virus sequence that was
inserted into the simulation data. The identity of the
resulting consensus virus genome with the initial se-
quence is 99.9%, in comparison with 99.1% between the
HPV-16 virus reference and the initial inserted sequence.
This result indicates that starting from a commonly used
virus reference genome, VERSE is able to generate a
consensus virus genome that better represents the virus
populations within a host.Effect of host genome customization
To show how well VERSE customizes host genomes, we
randomly chose a WGS sample, 26 T, from the 13 HCCs
(Table S1 in Additional file 1). The average coverage of
26 T is 65.5×. The HBV virus fused into this tumor gen-
ome at chr18:107920 as reported in [7].
We ran VERSE on the sequencing data of 26 T.
In total, 0.1 billion (4.1%) out of 2.4 billion reads were
recruited as viral reads. In step (c) of the pipeline,
VERSE used SVDetect to identify three genomic regions
(Chr3:140567185-140575795, Chr6:33823990-33832089,
and Chr18:102747-110847) as putative virus integration-
harboring regions. It is easy to see that the real virus
integration site, Chr18:107920, is located in the third
region.
Next, VERSE ran ICORN to iteratively customize
the three genomic regions. In each round of ICORN
customization, short reads were mapped against the
three regions and then consensus SNPs and indels were
identified from these regions for reference corrections.
The coverage of the mapped reads at each modified base
before and after correction was compared and the correc-
tion that reduced the coverage was rejected. We per-
formed 6 rounds of customization on this sample. Table 2
summarizes the total number of corrections accepted in
the three regions after ICORN terminated. As expected,
Wang et al. Genome Medicine  (2015) 7:2 Page 6 of 8majority corrections (87%) occurred in the third region,
which harbors the known virus integration site.
Figure 2 shows that read alignment was enhanced sub-
stantially after correcting SNPs and indels in the human
reference genome. In particular, alignment improvement
is more significant in the first two iterations, due to the
reason that the majority of nucleotide corrections occurred
therein.
With improved alignment, VERSE is able to recruit
more reads (of higher mapping quality) to detect virus
integration sites. An in-depth discussion of VERSE’s
performance in detecting virus integration sites is the
topic of the next section.
Virus integration site detection
More than half of our samples used WGS, currently the
most powerful sequencing technology. It provides the
most comprehensive and unbiased characterization of
genomic alterations (for example, gene fusions [41]) in
genomes. Many discovery-based studies applied WGS
technology to investigate the genome-wide associations
between virus integration and tumor genomic instability
[7-9]. One drawback of WGS is that, due to high sequen-
cing cost, the sequencing coverage of WGS is typically
between 30× and 60×, lower than that of other sequencing
technologies, such as whole exome sequencing and tar-
geted sequencing. Another challenge is that WGS requires
intensive computational analysis, for which many existing
tools are not capable.
In a previous study [28], WGS samples were used to
compare the computational efficiency of three software
tools: VirusSeq, ViralFusionSeq, and VirusFinder. That
study, however, did not evaluate the capabilities of the
three tools for detecting virus integration sites. With theFigure 2 The number of mapped reads as a function of ICORN
iteration. The total number of reads mapped to the three genomic
regions (Chr3:140567185-140575795, Chr6:33823990-33832089, and
Chr18:102747-110847) after each round of ICORN iteration. These
three regions were derived from SVDetect’s output for HBV+ tumor
sample 26 T (Table S1 in Additional file 1). The last region harbors a
HBV integration site.lack of benchmark evaluation, the accuracy of virus inte-
gration site identification from the WGS data remains
unclear to investigators. To the best of our knowledge,
the results below present the first systematic evaluation
of the sensitivity of virus integration detection in the
WGS samples.
As demonstrated previously [28], several virus integration
detection software, such as VirusSeq and ViralFusionSeq,
require exceedingly high CPU use when analyzing WGS
data. Considering the limited hardware resources, here we
compare VERSE primarily against VirusFinder [28] on the
WGS samples. VirusFinder is an efficient computational
tool for analyzing NGS data. In our benchmark experi-
ments, we ran VirusFinder in its normal mode (see user’s
manual at [30]).
Table 3 summarizes our benchmark results on the
human tumors and cancer cell lines. From the WGS sam-
ples, VERSE detected 16 (80%) out of 20 virus insertion
events, compared with 13 (65%) detected by VirusFinder.
Considering the difficulty in identifying virus integration
sites, and in comparison with somatic single nucleotide
variant detection, which has been intensely studied in the
scientific communities and hence represents a more ma-
ture technology, VERSE performed reasonably well on this
test data. Of note, the sensitivity of the state-of-the-art sin-
gle nucleotide variant-calling tools is estimated to be only
81 to 86% [42].
Additionally, Table 3 shows their comparative results
on the RNA-seq and TS samples. Again, VERSE outper-
formed VirusFinder, characterizing successfully 12 (86%)
out of 14 virus integration sites in these samples. Putting
all these results together, the overall sensitivity of VERSE
on our test data is 82% (28 out of 34), substantially
higher than 68% by VirusFinder.
Table 3 also presents the number of virus integration
sites detected by another tool, VirusSeq. VirusSeq is the
first public software in this field for identifying virus
integration sites in human tumor genomes. We down-
loaded the latest version of VirusSeq and ran it under its
default setting on our test data. As indicated in Table 3,Table 3 The number of virus integration sites detected by




WGS 20 16 13 -
RNA-seq 11 9 8 7
TS 3 3 2 3
Total 34 28 (82%) 23 (68%) -
aThe version of VirusVinder used in our experiment is release 6/19/2014. bThe
version of VirusSeq used in our experiment is the latest release (8/9/2013).
RNA-seq, whole transciptome sequencing; TS, targeted sequencing; WGS,
whole genome sequencing.
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sites from the RNA-seq and TS samples, less than the 12
(86%) detected by VERSE (see the overlap of their detec-
tion results in Additional file 2).
Finally, it may be worth mentioning the computational
efficiency of VERSE. With its well-designed pipeline, it
takes VERSE on average <3 days (using 8 CPUs) to analyze
a WGS sample on ACCRE (Table S3 in Additional file 1),
in comparison with 14 days by ViralFusionSeq and >11 days
by VirusSeq, as evaluated in [28]. This makes VERSE ideal
for efficient analysis of large-scale sequencing data. VERSE’s
speed and accuracy, together with its applicability to a wide
array of NGS platforms (WGS, RNA-seq, and TS), will
greatly benefit researchers in the field of virus sequencing
studies.Conclusions
Pathogenic viruses are constant health threats across the
globe. With the rapid advances in NGS technologies
over the past several years and their widespread applica-
tions in clinical settings, there is an increasing interest in
applying NGS to investigate the etiologic associations of
viruses with diseases, especially human cancer. Accurate
and comprehensive characterization of intra-host viruses
would not only improve our understanding of host-
pathogen interactions, molecular mechanisms of human
diseases, and genome evolution, but also facilitate the
development of successful antiviral treatments.
In this paper, we present VERSE, a novel approach
that enhances virus integration detection through better
read alignment. In particular, VERSE customizes both
virus and host reference genomes to create personalized
reference genomes, to which short reads align more eas-
ily. With improved alignment, VERSE is able to recruit
more reads (of higher mapping quality) to detect virus
integration sites. Using 19 human tumors and cancer
cell lines as test data, we demonstrated that VERSE
improved detection sensitivity substantially. VERSE has
been implemented in our open source package VirusFinder
2 [30].
VERSE requires the presence of both spanning and
soft-clipped reads to nominate a virus integration event.
Comparing with other tools that focus either on span-
ning reads or on split reads, this is a stringent require-
ment. Though effective and fast, a potential drawback of
this design is that it may miss real virus integration
events if there is no supportive soft-clipped reads. Fur-
ther improvement is needed in order not to miss real
virus integration sites. Another limitation of VERSE is
that ICORN, the tool used in VERSE for customizing
reference genomes, cannot process single-end reads. This
limits the applications of VERSE to paired-end sequencing
data at present.Additional files
Additional file 1: Tables S1 to S3. Thirteen WGS samples and the
validated HBV virus integration sites detected in them are described in
Table S1. Four RNA-seq samples and the validated viral-human chimeric
transcripts identified in them are provided in Table S2. Computation time
of VERSE and VirusFinder on 10 whole genome sequencing samples is
provided in Table S3.
Additional file 2: Figure S1. Overlap of the detection results of VERSE,
VirusFinder and VirusSeq on RNA-seq and targeted sequencing samples.
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